This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our and .
Healthcare
Food safety rating system to be voluntary
John Kaye, Greens NSW Member of Parliament, mentioned in the article below will be speaking on "How will cost implications of the carbon tax impact on food products" at the upcoming 13th annual Food Regulations and Labelling Standards conference on the 9-10 November 2011 in Sydney. *** THE NSW government will introduce a statewide ''scores…
7 Sep 2011, by Informa InsightsHealthcare
Adelaide shows off Australia’s first 5 Green Star hospital
Kriston Symons, Building Engineering - Group Leader of AECOM will be discussing this project in our upcoming 14th annual Healthcare Facilities Planning and Design Summit on the 27-28 September 2011 in Sydney. ______________________________________________________________________________ Adelaide’s redeveloped Flinders Medical Centre has become the country’s first hospital project to receive a 5 Star Green Star rating. The hospital’s…
5 Sep 2011, by Informa InsightsHealthcare | Planning & Design
Tasmania commits to green ratings for new public buildings
Delivering excellence in Environmentally Sustainable Design was defined as a key result area for the $160M Redevelopment of Flinders Medical Centre, and the New South Wing at FMC is the first project to be assessed under the Green Star Healthcare v1 Tool. The project has been awarded a 5 Star Green Star - Healthcare Design…
1 Sep 2011, by Informa InsightsHealthcare
Terry Barnes explains the biggest challenges in private health insurance today
We had the opportunity to speak with Terry Barnes, Principal of Cormorant Policy Advice and Former Senior Policy Advisor to Michael Woodridge and Tony Abbott, who is speaking at the 10th Annual Health Insurance Summit on the 26th and 27th Of July in Sydney. 1. What are the biggest challenges currently facing Australia's private health…
19 Jul 2011, by Informa InsightsHealthcare
Rising patient numbers and novel products are set to drive growth in the Chinese antidiabetics market
Melbourne, March 23, 2011 – Driven by the growing diabetic population and the improved healthcare insurance coverage implemented as part of the country's 2009 healthcare reform, the value of the overall diabetes drugs market in China will triple from $0.7bn in 2009 to $2.1bn in 2019, according to a new report from independent market analyst,…
25 Mar 2011, by Informa InsightsHealthcare
The Chinese hepatitis B market is set to triple by 2019
Melbourne, March15, 2011 – Fueled by the world’s largest hepatitis B patient pool, uptake of new therapies such as PEGylated interferons and Viread (tenofovir), and the government’s latest healthcare reforms, the Chinese hepatitis B market is set to continue its recent growth, and to triple in size by 2019, according to the latest analysis by…
15 Mar 2011, by Informa InsightsHealthcare
Battle against MRSA to net pharma industry US$2bn
Melbourne, 7th March 2011 - A number of new and expensive hospital brands targeting serious infections caused by multidrug-resistant bacteria, particularly MRSA*, will launch over the next decade. These will generate revenues totalling nearly US$2bn by 2019, according to independent market analyst Datamonitor.** However, the forecasted upside provided by these pipeline products will be insufficient…
7 Mar 2011, by Informa InsightsHealthcare
Will Australian Pharma ever be the same again?
Melbourne, 22nd February 2011 - The Australian pharmaceutical industry landscape is set to dramatically alter as a result of government changes to the Pharmaceutical Benefits Scheme (PBS), suggests independent market analyst, Datamonitor. Datamonitor’s outlook for the future includes withdrawn products, a struggling generics sector and wholesaler reorganization, as PBS reforms take effect. Erin Brady, Australian…
23 Feb 2011, by Informa InsightsHealthcare
Breast cancer cases on the rise in Japan
Melbourne, 18th February 2011. The number of women diagnosed with breast cancer per year in the seven major markets is forecast to increase by 13% over the next decade, finds independent healthcare analyst, Datamonitor.* However, in Japan, breast cancer incidence rates will rise by approximately 24% to 2019 to reach 56,400 cases, compared to 45,600…
18 Feb 2011, by Informa InsightsHealthcare
Diabetes pipeline cannot reverse cardiovascular and metabolic market decline
Melbourne, 10th February 2011 - Strong diabetes growth will not be enough to stop the cardiovascular and metabolic market from declining, finds independent market analyst Datamonitor.* Datamonitor forecasts that the cardiovascular and metabolic market across the seven major markets** will peak in 2011 and then begin to decline, with total sales falling from $105bn in…
10 Feb 2011, by Informa InsightsInforma Connect Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.
